Malinoski FJ - Search Results

1

Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial.

Girardi P, Harutyunyan S, Neuhauser I, Glaninger K, Korda O, Nagy G, Nagy E, Szijártó V, Pall D, Szarka K, Kardos G, Henics T, Malinoski FJ. Girardi P, et al. Among authors: malinoski fj. Vaccines (Basel). 2022 Feb 21;10(2):340. doi: 10.3390/vaccines10020340. Vaccines (Basel). 2022. PMID: 35214798 Free PMC article.

2

Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC.

Harutyunyan S, Neuhauser I, Mayer A, Aichinger M, Szijártó V, Nagy G, Nagy E, Girardi P, Malinoski FJ, Henics T. Harutyunyan S, et al. Among authors: malinoski fj. Vaccines (Basel). 2020 Nov 16;8(4):689. doi: 10.3390/vaccines8040689. Vaccines (Basel). 2020. PMID: 33207794 Free PMC article.

3

Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk.

McIntosh ED, Malinoski FJ, Randolph VB. McIntosh ED, et al. Among authors: malinoski fj. Expert Rev Vaccines. 2004 Aug;3(4):353-7. doi: 10.1586/14760584.3.4.353. Expert Rev Vaccines. 2004. PMID: 15270633 Review.

4

Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?

Fletcher MA, Laufer DS, McIntosh ED, Cimino C, Malinoski FJ. Fletcher MA, et al. Among authors: malinoski fj. Int J Clin Pract. 2006 Apr;60(4):450-6. doi: 10.1111/j.1368-5031.2006.00858.x. Int J Clin Pract. 2006. PMID: 16620359 Free PMC article. Review.

5

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.

Piedra PA, Grace S, Jewell A, Spinelli S, Bunting D, Hogerman DA, Malinoski F, Hiatt PW. Piedra PA, et al. Pediatr Infect Dis J. 1996 Jan;15(1):23-31. doi: 10.1097/00006454-199601000-00006. Pediatr Infect Dis J. 1996. PMID: 8684872 Clinical Trial.

6

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis.

Piedra PA, Grace S, Jewell A, Spinelli S, Hogerman DA, Malinoski F, Hiatt PW. Piedra PA, et al. Pediatr Infect Dis J. 1998 Mar;17(3):217-24. doi: 10.1097/00006454-199803000-00009. Pediatr Infect Dis J. 1998. PMID: 9535249 Clinical Trial.

7

Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.

Beletskii A, Galloway A, Rele S, Stone M, Malinoski F. Beletskii A, et al. Hum Vaccin Immunother. 2014;10(7):1908-13. doi: 10.4161/hv.28817. Hum Vaccin Immunother. 2014. PMID: 25424798 Free PMC article.

8

Pneumonia vaccine.

Malinoski FJ, Laufer DS. Malinoski FJ, et al. J Fam Pract. 2001 Oct;50(10):902. J Fam Pract. 2001. PMID: 11674899 No abstract available.

9

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.

Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F. Black SB, et al. Pediatr Infect Dis J. 2001 Dec;20(12):1105-7. doi: 10.1097/00006454-200112000-00002. Pediatr Infect Dis J. 2001. PMID: 11740313 Clinical Trial.

10

Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunization.

Parijs BA, Malinoski FJ. Parijs BA, et al. Among authors: malinoski fj. Mech Ageing Dev. 2004 Feb;125(2):147-8. doi: 10.1016/j.mad.2003.12.001. Mech Ageing Dev. 2004. PMID: 15037021 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page